Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Accelerated Aspirin Degradation in Pill Organizers

View through CrossRef
This aim of this study was to survey the rate of accelerated degradation of coated and uncoated aspirin tablets stored in pill organizers (POs). POs are multi-compartment boxes that patients commonly use to sort pills, especially if the medication regime is complex. The use of POs involves removing the pill from its original package and placing it in the compartment for extended periods of time. Although an effective sorting tool, POs might allow accelerated degradation of the drug since medications are subjected to more light, humidity and temperature. Degradation of medications entails many health hazards and concerns, hence the importance of assessing the rate of formation of degradation by products. A 31-compartment PO, which is commonly used at local retirement houses, was investigated. It is typically placed in a drug cabinet inside a bathroom. Aspirin degrades by hydrolysis to form salicylic acid, which causes stomach irritation. pH titration of aspirin tablets in PO and in original packaging was used to qualitatively establish that aspirin undergoes accelerated degradation in POs placed in bathroom drug cabinets. The percentage of free salicylic acid in coated and uncoated aspirin tablets was measured using high performance liquid chromatography (HPLC). %SA in uncoated tablets reached 1.503%, which is five times above the USP limit of 0.30%. Uncoated tablets reach the maximum limit after 18 days of storage in PO. Coated tablets remained within the prescribed USP limit of 3.0%. The findings of the study established that storing aspirin pills in POs for extended periods of time is an inappropriate practice as it accelerates the rate at which tablets undergo hydrolysis degradation.
Title: Accelerated Aspirin Degradation in Pill Organizers
Description:
This aim of this study was to survey the rate of accelerated degradation of coated and uncoated aspirin tablets stored in pill organizers (POs).
POs are multi-compartment boxes that patients commonly use to sort pills, especially if the medication regime is complex.
The use of POs involves removing the pill from its original package and placing it in the compartment for extended periods of time.
Although an effective sorting tool, POs might allow accelerated degradation of the drug since medications are subjected to more light, humidity and temperature.
Degradation of medications entails many health hazards and concerns, hence the importance of assessing the rate of formation of degradation by products.
A 31-compartment PO, which is commonly used at local retirement houses, was investigated.
It is typically placed in a drug cabinet inside a bathroom.
Aspirin degrades by hydrolysis to form salicylic acid, which causes stomach irritation.
pH titration of aspirin tablets in PO and in original packaging was used to qualitatively establish that aspirin undergoes accelerated degradation in POs placed in bathroom drug cabinets.
The percentage of free salicylic acid in coated and uncoated aspirin tablets was measured using high performance liquid chromatography (HPLC).
%SA in uncoated tablets reached 1.
503%, which is five times above the USP limit of 0.
30%.
Uncoated tablets reach the maximum limit after 18 days of storage in PO.
Coated tablets remained within the prescribed USP limit of 3.
0%.
The findings of the study established that storing aspirin pills in POs for extended periods of time is an inappropriate practice as it accelerates the rate at which tablets undergo hydrolysis degradation.

Related Results

Management Options for Patients with Aspirin and Nonsteroidal Antiinflammatory Drug Sensitivity
Management Options for Patients with Aspirin and Nonsteroidal Antiinflammatory Drug Sensitivity
Objective: To evaluate and provide management strategies for patients with aspirin or nonselective nonsteroidal antiinflammatory drug (NSAID) sensitivity. Data Sources: Literature ...
Abstract 5758: Regular aspirin use, breast tumor characteristics and long-term breast cancer survival
Abstract 5758: Regular aspirin use, breast tumor characteristics and long-term breast cancer survival
Abstract Compelling epidemiologic data, supported by experimental evidence, suggest aspirin may improve survival in breast cancer patients. However, recent clinical ...
DETERMINANTS OF PILL FAILURE IN RURAL BANGLADESH
DETERMINANTS OF PILL FAILURE IN RURAL BANGLADESH
The pill is the most popular family planning method in Bangladesh. However, the failure rate of this method in Matlab, a typical rural area, has been found to be very high. It is e...
Long‐term use of low‐dose aspirin for cancer prevention: A 10‐year population cohort study in Hong Kong
Long‐term use of low‐dose aspirin for cancer prevention: A 10‐year population cohort study in Hong Kong
Aspirin, commonly used for prevention of cardiovascular and cerebrovascular diseases, has been found to possess protective effects against cancer development in the Western populat...
Abstract 793: NOSH-aspirin and 5-fluorouracil demonstrate synergistic efficacy in a xenograft model of colon cancer
Abstract 793: NOSH-aspirin and 5-fluorouracil demonstrate synergistic efficacy in a xenograft model of colon cancer
Abstract Introduction: Work in cancer biology, epidemiology and preclinical models has made it clear that non-steroidal anti-inflammatory drugs (NSAIDs) in general a...
Aspirin resistance in infants with shunt-dependent congenital heart disease
Aspirin resistance in infants with shunt-dependent congenital heart disease
AbstractIntroduction:Patients with cyanotic heart disease are at an increased risk of developing thrombosis. Aspirin has been the mainstay of prophylactic anticoagulation for shunt...
Aspirin usage in patients with essential hypertension
Aspirin usage in patients with essential hypertension
Objective To investigate the use of aspirin in patients with essential hypertension complicated with different risk factors and clinical conditions. ...

Back to Top